Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00752
|
|||||
| Drug Name |
GS-6615
|
|||||
| Synonyms |
1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-(4-(trifluoromethoxy)phenyl)-; 1443211-72-0; 4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one; AKOS030627706; AS-35245; CHEMBL3707392; DB12394; Eleclazine; Eleclazine (USAN/INN); Eleclazine [INN]; Eleclazine [USAN:INN]; Eleclazine(GS-6615); GS-6615; GS6615; GTPL8413; J3.563.176C; KS-000006B4; MolPort-044-723-855; PUY08529FK; SB19622; SCHEMBL14480722; UNII-PUY08529FK; YNUAEEJQYHYLMS-UHFFFAOYSA-N; ZINC206191652
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H16F3N3O3
|
|||||
| Canonical SMILES |
C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4
|
|||||
| InChI |
InChI=1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2
|
|||||
| InChIKey |
YNUAEEJQYHYLMS-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 415.4 | Topological Polar Surface Area | 64.599 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
3.7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.